During the past decade, Fakultna nemocnica Trencín; Onkologicke odd. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fakultna nemocnica Trencín; Onkologicke odd." are "Breast Cancer" (2 trials), "Breast Neoplasms" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Fakultna nemocnica Trencín; Onkologicke odd." in a lesser frequency.

Most popular intervention types in "Fakultna nemocnica Trencín; Onkologicke odd." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Herceptin" (1 trials), "Trastuzumab Emtansine" (1 trials) and "Trastuzumab emtansine (T-DM1)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fakultna nemocnica Trencín; Onkologicke odd." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fakultna nemocnica Trencín; Onkologicke odd.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fakultna nemocnica Trencín; Onkologicke odd., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultna nemocnica Trencín; Onkologicke odd., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".